Welcome to the
Galenica network.
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market.
Annual report 2023: We create added value for the healthcare system
The 2023 financial year was characterised by opportunities, changes and challenges. At 4.4%, we once again achieved strong growth and further developed Galenica.
Perspectives in the Galenica network
![Woman with headset behind two screens](/galenica23Assets/img/home/weblication/wThumbnails/47a19171-4ae1949f@811w.jpg)
Conference Call – Half year results 2024
6 August 2024
2.00 p.m.
Meeting: 84068944345, Identification code: 8284
![A doctor kneels in front of the patient, a boy](/galenica23Assets/img/medien/news/weblication/wThumbnails/7184ddac-4ae1949f@811w.jpg)
Change in management at Pharmapool
Daniel Bühler became the new head of the Pharmapool Ltd. Business Unit on 1 June 2024. From 1 August 2024, he will also take over as Head of Project and Integration Management at Galexis.
![Two hikers look into the forest and smile](/galenica23Assets/img/corporate-information/weblication/wThumbnails/1d82cc25-4ae1949f@811w.jpg)
Galenica on track with sales growth
The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024.
Corporate
Information
Galenica (SIX Swiss Exchange)
76.15 CHF
Volume
0.00
07/26/2024 17:30
![Marc Werner, CEO](/galenica23Assets/img/management/weblication/wThumbnails/e1bf6ecc-db5257eb@800w.jpg)
«We have embedded our network philosophy even more firmly into our strategy. Clients will benefit from a comprehensive range of services from a single source.»